Galleon Pharmaceuticals lands $10M for sleep apnea, COPD drug
Galleon Pharmaceuticals Inc. in suburban Philadelphia has raised $10 million to help discover medicines to treat breathing control conditions, like sleep apnea and COPD.
Galleon Pharmaceuticals